申请人:Barker David Michael
公开号:US20060178416A1
公开(公告)日:2006-08-10
There are provided according to the invention novel compounds of formula (I)
or pharmaceutically acceptable salts thereof, wherein R1, R2, R19, R20, and R34 are as described in the specification, processes for preparing them, formulations containing them and their use in therapy for the treatment of inflammatory diseases.
根据本发明提供了公式(I)的新化合物或其药学上可接受的盐,其中R1、R2、R19、R20和R34如规范所述,以及制备它们的过程、包含它们的制剂和它们在治疗炎症性疾病方面的用途。